2m 2m 2m 2m 2m 2m 2m
Lifecore Biomed (LFCR)
NASDAQ
$5.64-$0.02 (-0.35%)
Price as of Jun 23, 2026 4:10 PM EDT- $207.4MMarket Cap
- -31.64%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Lifecore Biomed (LFCR)
$5.64-$0.02 (-0.35%)
LFCR | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $5.66 | ||
Change | +$0.13 (+2.35%) | ||
Open | $5.51 | ||
High | $5.73 | ||
Low | $5.51 | ||
Previous Close | $5.53 | ||
Volume | 104,369 | ||
30-Day Average Volume | 181,199 | ||
1-Week Change | 5.79% | ||
1-Month Change | 14.81% | ||
1-Year Change | -31.64% | ||
3-Year Change | -36.48% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 37.5M | ||
Total Assets | $225.5M | ||
Market Cap | $207.4M | ||
Enterprise Value | $198.5M | ||
Period: QTR TTM FY | |||
Revenue | $14.2M | ||
Net Income | -$15.0M | ||
Free Cash Flow | N/A | ||
EBIT | -$7.7M | ||
EBITDA | -$5.4M | ||
Net Working Capital | N/A | ||
EPS | -$0.43 | ||
Enterprise Value/EBITDA | -37 | ||
Enterprise Value/Revenue | 14 | ||
P/B | -7 | ||
P/E | -13 | ||
PEG | 0 | ||
Price/Free Cash Flow | N/A | ||
Price/Operating Cash Flow | N/A | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue